4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001493152-26-033167
Options or other derivatives
- CFO acquired 1,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Shah Amit B. CFO | 2026-07-10 | Grant or award · Restricted stock Units | +1,500 | 1,500 | D | ||
Loading xslF345X06/ownership.xml…